Trevena Inc financial data

Symbol
TRVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 454 % +5.45%
Quick Ratio 11.6 % -51.7%
Debt-to-equity -471 % -326%
Return On Equity 393 %
Return On Assets -106 % -22.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.3M shares +55.5%
Common Stock, Shares, Outstanding 21.3M shares +55.5%
Entity Public Float 12M USD -95.7%
Common Stock, Value, Issued 21K USD +50%
Weighted Average Number of Shares Outstanding, Basic 21.3M shares +84.1%
Weighted Average Number of Shares Outstanding, Diluted 21.3M shares +84.1%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 1.65M USD -41.4%
Research and Development Expense 15.5M USD -6.26%
General and Administrative Expense 18.6M USD -24.4%
Costs and Expenses 35.8M USD -18.7%
Operating Income (Loss) -35.4M USD +14.6%
Nonoperating Income (Expense) -1.67M USD -151%
Net Income (Loss) Attributable to Parent -37M USD +2.9%
Earnings Per Share, Basic -2.25 USD/shares +48.3%
Earnings Per Share, Diluted -2.25 USD/shares +48.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.4M USD -41.7%
Accounts Receivable, after Allowance for Credit Loss, Current 179K USD
Inventory, Net 900K USD +14.7%
Assets, Current 18M USD -45.3%
Property, Plant and Equipment, Net 1.02M USD -24.2%
Operating Lease, Right-of-Use Asset 3.35M USD -15.2%
Other Assets, Noncurrent 43K USD
Assets 22.9M USD -41%
Accounts Payable, Current 1.13M USD -55.2%
Employee-related Liabilities, Current 2.09M USD +6.51%
Liabilities, Current 5.21M USD -36.3%
Operating Lease, Liability, Noncurrent 3.87M USD -21.5%
Liabilities 41.9M USD +44.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1K USD
Retained Earnings (Accumulated Deficit) -601M USD -6.57%
Stockholders' Equity Attributable to Parent -19M USD -294%
Liabilities and Equity 22.9M USD -41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.42M USD +13.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 21.3M shares +55.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.42M USD +13.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.9M USD -41%
Deferred Tax Assets, Valuation Allowance 157M USD +6.24%
Deferred Tax Assets, Gross 157M USD +6.27%
Operating Lease, Liability 4.94M USD -16.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.1M USD +11%
Lessee, Operating Lease, Liability, to be Paid 5.87M USD -19.7%
Property, Plant and Equipment, Gross 3.79M USD -10.7%
Operating Lease, Liability, Current 1.06M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.5M USD +1.63%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.47M USD +1.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 930K USD -34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.52M USD +1.67%
Deferred Tax Assets, Operating Loss Carryforwards 55.8M USD +20.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 640K USD -58%
Operating Lease, Payments 122K USD -4.69%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 88K USD +7.32%
Share-based Payment Arrangement, Expense 681K USD -15.5%
Interest Expense 3.11M USD -53.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%